An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a ...
Merck (NYSE:MRK) has initiated a late-stage trial to test its experimental drug, MK-1084, in combination with its anti-PD1 immunotherapy KEYTRUDA (pembrolizumab) for the first-line treatment of ...
Add Yahoo as a preferred source to see more of our stories on Google. Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - Merck & Co said on Wednesday it plans to ...
One of the largest pharmaceutical companies in the world is testing the delivery of vaccines via drone to get them to patients faster. Merck is working with Volansi, a commercial drone delivery ...
March 13 (Reuters) - Merck & Co (MRK.N), opens new tab said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results